SLC25A4 and rheumatoid arthritis: Notably, SLC25A4 has also been reported to be upregulated in human PBMCs treated with vitamin D3, a key modulator of the immune system [32], and downregulated in PBMCs from patients with rheumatoid arthritis [33].